Mutational Biosynthesis of Ansamitocin Antibiotics: A Diversity-Oriented Approach to Exploit Biosynthetic Flexibility

Research output: Contribution to journalArticleResearchpeer review

Authors

  • Tobias Knobloch
  • Kirsten Harmrolfs
  • Florian Taft
  • Binia Thomaszewski
  • Florenz Sasse
  • Andreas Kirschning

External Research Organisations

  • Helmholtz Centre for Infection Research (HZI)
View graph of relations

Details

Original languageEnglish
Pages (from-to)540-547
Number of pages8
JournalChemBioChem
Volume12
Issue number4
Publication statusPublished - 27 Jan 2011

Abstract

New ansamitocin derivatives were prepared by feeding aminobenzoic acid derivatives to cultures of Actinosynnema pretiosum HGF073, a mutant strain blocked in the biosynthesis of the required 3-amino-5-hydroxybenzoic acid (AHBA) starter unit. Use of several aminobenzoic acids as precursors led to a spectrum of products, reflecting the sequence of post-PKS tailoring steps involved in the generation of ansamitocins and adding novel aspects to the published suggestion model of post-PKS tailoring logic and flexibility. The studies provide insights into the substrate flexibility of the enzymes required for ansamitocin biosynthesis in A. pretiosum, whereas preliminary biological testing of the derivatives isolated and fully characterized by NMR spectroscopy allowed structure-activity relationship assignments to be made for a variety of intermediates occurring during the post-PKS tailoring sequence in ansamitocin biosynthesis. Mutasynthesis: Feeding aminobenzoic acid derivatives to a Actinosynnema pretiosum mutant that could not biosynthesize the essential starter unit 3-amino-5-hydroxybenzoic acid led to novel ansamitocin derivatives, which were isolated, characterized and subjected to in vitro biological testing. Our studies provided insights into the flexibility of ansamitocin biosynthesis in A. pretiosum and gave a deeper understanding of structure-activity relationships.

Keywords

    Ansamitocin, Antitumor agents, Mutasynthesis, Polyketide biosynthesis, Structure-activity relationships

ASJC Scopus subject areas

Cite this

Mutational Biosynthesis of Ansamitocin Antibiotics: A Diversity-Oriented Approach to Exploit Biosynthetic Flexibility. / Knobloch, Tobias; Harmrolfs, Kirsten; Taft, Florian et al.
In: ChemBioChem, Vol. 12, No. 4, 27.01.2011, p. 540-547.

Research output: Contribution to journalArticleResearchpeer review

Knobloch T, Harmrolfs K, Taft F, Thomaszewski B, Sasse F, Kirschning A. Mutational Biosynthesis of Ansamitocin Antibiotics: A Diversity-Oriented Approach to Exploit Biosynthetic Flexibility. ChemBioChem. 2011 Jan 27;12(4):540-547. doi: 10.1002/cbic.201000608
Knobloch, Tobias ; Harmrolfs, Kirsten ; Taft, Florian et al. / Mutational Biosynthesis of Ansamitocin Antibiotics : A Diversity-Oriented Approach to Exploit Biosynthetic Flexibility. In: ChemBioChem. 2011 ; Vol. 12, No. 4. pp. 540-547.
Download
@article{45f4224434e44f8c817b8b5c41e0f06d,
title = "Mutational Biosynthesis of Ansamitocin Antibiotics: A Diversity-Oriented Approach to Exploit Biosynthetic Flexibility",
abstract = "New ansamitocin derivatives were prepared by feeding aminobenzoic acid derivatives to cultures of Actinosynnema pretiosum HGF073, a mutant strain blocked in the biosynthesis of the required 3-amino-5-hydroxybenzoic acid (AHBA) starter unit. Use of several aminobenzoic acids as precursors led to a spectrum of products, reflecting the sequence of post-PKS tailoring steps involved in the generation of ansamitocins and adding novel aspects to the published suggestion model of post-PKS tailoring logic and flexibility. The studies provide insights into the substrate flexibility of the enzymes required for ansamitocin biosynthesis in A. pretiosum, whereas preliminary biological testing of the derivatives isolated and fully characterized by NMR spectroscopy allowed structure-activity relationship assignments to be made for a variety of intermediates occurring during the post-PKS tailoring sequence in ansamitocin biosynthesis. Mutasynthesis: Feeding aminobenzoic acid derivatives to a Actinosynnema pretiosum mutant that could not biosynthesize the essential starter unit 3-amino-5-hydroxybenzoic acid led to novel ansamitocin derivatives, which were isolated, characterized and subjected to in vitro biological testing. Our studies provided insights into the flexibility of ansamitocin biosynthesis in A. pretiosum and gave a deeper understanding of structure-activity relationships.",
keywords = "Ansamitocin, Antitumor agents, Mutasynthesis, Polyketide biosynthesis, Structure-activity relationships",
author = "Tobias Knobloch and Kirsten Harmrolfs and Florian Taft and Binia Thomaszewski and Florenz Sasse and Andreas Kirschning",
year = "2011",
month = jan,
day = "27",
doi = "10.1002/cbic.201000608",
language = "English",
volume = "12",
pages = "540--547",
journal = "ChemBioChem",
issn = "1439-4227",
publisher = "Wiley-VCH Verlag",
number = "4",

}

Download

TY - JOUR

T1 - Mutational Biosynthesis of Ansamitocin Antibiotics

T2 - A Diversity-Oriented Approach to Exploit Biosynthetic Flexibility

AU - Knobloch, Tobias

AU - Harmrolfs, Kirsten

AU - Taft, Florian

AU - Thomaszewski, Binia

AU - Sasse, Florenz

AU - Kirschning, Andreas

PY - 2011/1/27

Y1 - 2011/1/27

N2 - New ansamitocin derivatives were prepared by feeding aminobenzoic acid derivatives to cultures of Actinosynnema pretiosum HGF073, a mutant strain blocked in the biosynthesis of the required 3-amino-5-hydroxybenzoic acid (AHBA) starter unit. Use of several aminobenzoic acids as precursors led to a spectrum of products, reflecting the sequence of post-PKS tailoring steps involved in the generation of ansamitocins and adding novel aspects to the published suggestion model of post-PKS tailoring logic and flexibility. The studies provide insights into the substrate flexibility of the enzymes required for ansamitocin biosynthesis in A. pretiosum, whereas preliminary biological testing of the derivatives isolated and fully characterized by NMR spectroscopy allowed structure-activity relationship assignments to be made for a variety of intermediates occurring during the post-PKS tailoring sequence in ansamitocin biosynthesis. Mutasynthesis: Feeding aminobenzoic acid derivatives to a Actinosynnema pretiosum mutant that could not biosynthesize the essential starter unit 3-amino-5-hydroxybenzoic acid led to novel ansamitocin derivatives, which were isolated, characterized and subjected to in vitro biological testing. Our studies provided insights into the flexibility of ansamitocin biosynthesis in A. pretiosum and gave a deeper understanding of structure-activity relationships.

AB - New ansamitocin derivatives were prepared by feeding aminobenzoic acid derivatives to cultures of Actinosynnema pretiosum HGF073, a mutant strain blocked in the biosynthesis of the required 3-amino-5-hydroxybenzoic acid (AHBA) starter unit. Use of several aminobenzoic acids as precursors led to a spectrum of products, reflecting the sequence of post-PKS tailoring steps involved in the generation of ansamitocins and adding novel aspects to the published suggestion model of post-PKS tailoring logic and flexibility. The studies provide insights into the substrate flexibility of the enzymes required for ansamitocin biosynthesis in A. pretiosum, whereas preliminary biological testing of the derivatives isolated and fully characterized by NMR spectroscopy allowed structure-activity relationship assignments to be made for a variety of intermediates occurring during the post-PKS tailoring sequence in ansamitocin biosynthesis. Mutasynthesis: Feeding aminobenzoic acid derivatives to a Actinosynnema pretiosum mutant that could not biosynthesize the essential starter unit 3-amino-5-hydroxybenzoic acid led to novel ansamitocin derivatives, which were isolated, characterized and subjected to in vitro biological testing. Our studies provided insights into the flexibility of ansamitocin biosynthesis in A. pretiosum and gave a deeper understanding of structure-activity relationships.

KW - Ansamitocin

KW - Antitumor agents

KW - Mutasynthesis

KW - Polyketide biosynthesis

KW - Structure-activity relationships

UR - http://www.scopus.com/inward/record.url?scp=79952015068&partnerID=8YFLogxK

U2 - 10.1002/cbic.201000608

DO - 10.1002/cbic.201000608

M3 - Article

C2 - 22238146

AN - SCOPUS:79952015068

VL - 12

SP - 540

EP - 547

JO - ChemBioChem

JF - ChemBioChem

SN - 1439-4227

IS - 4

ER -

By the same author(s)